Sort
21,453 grants matching “tuberculosis”
Adjuvants for Skin Immunization: Discovery and Mechanisms
$785,860Ioanna Skountzou · Emory University · R01 · FY2016 · AI
Stellenbosch University Clinical Trial Unit, Cape Town, South Africa
$785,614Mark Fredric Cotton · Stellenbosch University · UM1 · FY2013 · AI
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
$785,512Scott K Heysell · University Of Virginia · R01 · FY2024 · AI
iPSC-derived macrophages as a model to study the genetic basis of inter-individual variation in immune responses to pathogens
$785,511Luis Bruno Barreiro · University Of Chicago · R01 · FY2025 · AI
Host-Directed Strategies to Create Synergistic Antibacterial Therapies
$785,000Jeffery S Cox · University Of California Berkeley · DP1 · FY2017 · AI
Host-Directed Strategies to Create Synergistic Antibacterial Therapies
$785,000Jeffery S Cox · University Of California Berkeley · DP1 · FY2016 · AI
Host-Directed Strategies to Create Synergistic Antibacterial Therapies
$785,000Jeffery S Cox · University Of California Berkeley · DP1 · FY2018 · AI
Host-Directed Strategies to Create Synergistic Antibacterial Therapies
$785,000Jeffery S Cox · University Of California Berkeley · DP1 · FY2019 · AI
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
$784,938Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Task 6: Technical Support for Tuberculosis Therapeutics
$784,792Sri International · N01 · FY2012 · AI
Novel Pathogen Associated Cancers (PQ12)
$784,723Denise A. Galloway · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA
The role of tyrosine metabolism in tuberculosis pathogenesis
$784,531Sara Suliman · University Of California, San Francisco · R01 · FY2025 · AI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
$784,326Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
East Africa IEDEA Regional Consortium
$784,312Constantin T Yiannoutsos · Indiana University Indianapolis · U01 · FY2009 · AI
Spectinomycin analogs for NTM infections
$784,246Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2023 · AI
One-carbon metabolism and immune cell function in tuberculosis
$784,181Lanbo Shi · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
PS05-003, TUBERCULOSIS ELIMINATION AND LABORATORY
$784,028Jon Tillinghast · Oklahoma State Department Of Health · U52 · FY2008 · PS
PS05-003, TUBERCULOSIS ELIMINATION AND LABORATORY
$783,877Lauri Smithee · Oklahoma State Department Of Health · U52 · FY2009 · PS
The effect of HIV exposure and infection on immunity to TB in children
$783,833Grace C John-Stewart · University Of Washington · R01 · FY2021 · AI
ART Adherence: Observed Therapy and Enhanced Counseling
$783,831Kathy J Goggin · University Of Missouri Kansas City · R01 · FY2006 · MH
METABOLIC ALDEHYDES AS IMMUNE EFFECTORS AGAINST TUBERCULOSIS
$783,685Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2024 · AI
Columbia University-Southern African AIDS International Training/Research Program
$783,551Quarraisha Abdool Karim · Columbia University Health Sciences · D43 · FY2014 · TW
The Impact of Tolerance in the Newborn on Lentiviral Infection
$783,538Joseph M McCune · University Of California, San Francisco · R01 · FY2010 · AI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$783,413John R. Chan · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Admixture Mapping of Sarcoidosis Genes in African American
$783,269Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2008 · HL